David Tietze, MD
Internal Medicine · Dallas, TXNPI 1700029196
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,345 of the $1,579 with a category attached, or 85.2%. 8 manufacturers reported payments, led by Pylant Medical at 34.0% of the total.
Across 41 payments — averaging $38.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$537
- Arthrex$278
- Ferring Pharmaceuticals Inc.$247
- Bioventus LLC$199
- Trice Medical, Inc.$85
- DJO, LLC$81
- plus $152 from 2 others
Across 1 payment — averaging $24,549 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Miach Orthopaedics, Inc.$25K
What the payments were for
- Travel & lodging$23415%
- Food & beverage$1,34585%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 10 | $537 |
| Arthrex | 4 | $278 |
| Ferring Pharmaceuticals Inc. | 11 | $247 |
| Bioventus LLC | 5 | $199 |
| Trice Medical, Inc. | 1 | $85 |
| DJO, LLC | 1 | $81 |
| Johnson & Johnson | 5 | $77 |
| Amgen | 4 | $75 |
How this compares
$1,579 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 159 | $928 |
| Baclofen | 52 | $299 |
| Methylprednisolone | 52 | $258 |
| Tramadol Hcl | 77 | $231 |
| Meloxicam | 101 | $190 |
| Gabapentin | 23 | $182 |
| Ibuprofen | 25 | $123 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $119 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dallas
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Han SchmidlyDallas$465K
- Athica VatanapradithDallas$164K
- Nicholaos BellosDallas$113K
- Steven HeldDallas$65K
- Amit VermaDallas$53K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Mohammed Al-NajjarEl Paso$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.